About uMed
Our mission is to improve the lives of those living with disease by enabling access to the data and insights needed to bring new therapies and innovations to patients.
.png)
Our story
Our story
Across the therapy lifecycle, many unanswered questions hold back the development and adoption of treatments that could improve outcomes for patients. Yet the traditional routes to evidence generation often leave these important research questions unresolved.
uMed addresses these critical evidence gaps by enabling access to the data and insights needed to accelerate the development and delivery of new medicines and innovations to patients.
uMed addresses these critical evidence gaps by enabling access to the data and insights needed to accelerate the development and delivery of new medicines and innovations to patients.
The team
Meet the leadership team
Dr Matt Wilson
Founder & Chief Executive Officer
Bill Petitto
Chief Business Officer
Lily Batt
VP of Operations
Kavita Sundararajan
Chief Product & Technology officer
Hannah Sharp
Director of Patient, Nursing and Medical Services
Caroline Smithers
VP of Finance
Serena Macleod
Global Commercial and Partnership Director
Rachel Burgess
Director of People and Culture
The team
Meet our board
Carol Lynch
Executive Chair
Christopher Spray
Delin Ventures
Paul Bleicher
Independent Board Member
Advisory Board
Anchored by leading scientific experts
Asc Prof. Mark Toshner
Principal Investigator
Professor at the University of Cambridge, Director of the NIHR Clinical Research Facility in the VPD Heart & Lung Research Institute and an Honorary Consultant in Royal Papworth NHS Trust.
Prof. Naveed Sattir
Cardiometabolic Advisory Chair
University of Glasgow. Internationally recognised in cardiometabolic disease. Professor Sattar has contributed to multiple pharmaceutical trials and to eight national and international guidelines. He has co-authored over 1300 published papers
Prof. Alastair Noyce
Chief Investigator
Professor at the University of Cambridge, Director of the NIHR Clinical research Facility in the VPD Heart & Lung Research Institute and an Honorary Consultant in Royal Papworth NHS Trust.
Timothy Michael Dempsey
Chief Investigator
Timothy Michael Dempsey is a health care provider primarily located in Travis AFB, California in the United States. He specialises in Pulmonology, Critical Care Medicine, and Internal Medicine.
Prof. Phil Molyneaux
Cardiometabolic Advisory Chair
Phil is a Professor of Interstitial lung disease at Imperial College London. He is the Asthma+Lung UK Chair of Respiratory Research and Consultant in Interstitial lung disease at the Royal Brompton Hospital, where he is also the director of the NIHR Clinical Research Facility.
Prof. Nick Fuggle
Investigator
Turing Fellowship at the Alan Turing Institute. Numerous national and international awards, including the British Society of Rheumatology Young Investigator Award and the International Osteoporosis Foundation Pierre Meunier Award.
Careers at uMed
Join our mission
We’re a curious, passionate team on a mission to make medical research more accessible and effective.
At uMed, everyone has the freedom to create, take risks, and shape solutions that genuinely improve lives.k oWe work hard, laugh often, and stay grounded in the belief that what we do truly matters.
CareersAt uMed, everyone has the freedom to create, take risks, and shape solutions that genuinely improve lives.k oWe work hard, laugh often, and stay grounded in the belief that what we do truly matters.
Flexible Working
We want each individual to work in a way that suits them. We offer the ability to work flexibly and remotely, but we are a social bunch, so we have regular in-person team days!
Passionate
Every member of our team is passionate about uMed's solutions and the impact we are having on the acceleration of medical research. We encourage creative thinking for ongoing innovation and improvement.
Inclusive
Inclusivity is embedded in our entire business; from our products which improve representation from minority groups within research, to the equitable access and opportunities we make available to everyone within our team.
“I joined uMed in October 2022, having previously worked for the NIHR CRN Greater Manchester for over 10 years. It's been an exciting role so far! uMed is the sort of company where change and innovation is encouraged, so you feel you can make a significant impact quickly.”
Helen O’Brien
Healthcare Coordinator
Partnerships
uMed Announces Strategic Partnership with WellSky® to Expand Patient Access to National Clinical Research Registries
Read the press releaseRecent company news
Real-time, technology enabled data collection ensures that you have the most up-to-date insights, minimizing gaps and errors in data.
Company News
Partners
October 30, 2025
Partnering with WellSky to expand the reach of real-world data
Read more
Company News
Product
May 1, 2025
uMed Launches SnapACCESS: A Groundbreaking Solution for Agile and Compliant Patient Data Insights in Diabetes and Obesity Research
Read more
Company News
November 21, 2024
uMed’s AccessPD Interactive Parkinson’s Registry Surpasses 1000 Participants
Read more
Book a complimentary demonstration.
For a clear picture of how uMed could work for you, book a free session with our team.
hello@umed.io
hello@umed.io
